Dr. Sandy Srinivas
Stanford University
11
11
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+8 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (11)
Showing 10 of 11 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Rahul Aggarwal, MD
University of California, San Francisco
Shared therapeutic areas:
Worked with same sponsors:
Primo N. Lara, MD
University of California, Davis
Shared therapeutic areas:
Worked with same sponsors:
Chi Fai Ng, MD
Chinese University of Hong Kong
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Zhaohui Zhu, MD
Peking Union Medical College Hospital
Shared therapeutic areas:
Worked with same sponsors:
John D. Hainsworth, MD
SCRI Development Innovations, LLC
Shared therapeutic areas:
Worked with same sponsors:
Kevin A camphausen, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
howard Safran, MD
Brown University
Shared therapeutic areas:
Worked with same sponsors:
Lorenzo Cohen, PhD
M.D. Anderson Cancer Center
Shared therapeutic areas:
James L Gulley, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (11)
Showing 11 of 11 trials
Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer
A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer
Fulvestrant in Hormone Refractory Prostate Cancer
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy
All 11 trials loaded